[CAS NO. 1029877-94-8]  Trelagliptin succinate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1029877-94-8]

Store
Catalog
SLK-S5063
Brand
Selleck
CAS
1029877-94-8

DESCRIPTION [1029877-94-8]

Overview

MDLMFCD22665720
Molecular Weight475.47
Molecular FormulaC18H20FN5O2.C4H6O4
SMILESN#CC1=CC=C(F)C=C1CN(C(N2C)=O)C(N3C[C@H](N)CCC3)=CC2=O.O=C(O)CCC(O)=O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.1032 mL10.5159 mL21.0318 mL
5 mM0.4206 mL2.1032 mL4.2064 mL
10 mM0.2103 mL1.0516 mL2.1032 mL
50 mM0.0421 mL0.2103 mL0.4206 mL

Description

Trelagliptin succinate (SYR472) is a inhibitor which is used as a new long-acting drug for once-weekly treatment of type 2 diabetes mellitus (DM).

Targets

DPP-4 [1]
(Cell-free assay)
4 nM

In vitro

Trelagliptin is selective over other related DPP enzymes, P450 enzymes and hERG channel. It exhibits approximately 4- and 12-fold more potent inhibition against human dipeptidyl peptidase-4 than alogliptin and sitagliptin, respectively, and >10,000-fold selectivity over related proteases including dipeptidyl peptidase-8 and dipeptidyl peptidase-9. Kinetic analysis reveals reversible, competitive and slow-binding inhibition of dipeptidyl peptidase-4 by trelagliptin (t1/2 for dissociation ≈ 30 minutes). X-ray diffraction data indicates a non-covalent interaction between dipeptidyl peptidase and trelagliptin.